Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001510852 | SCV001717994 | benign | Smith-Lemli-Opitz syndrome | 2024-02-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001510852 | SCV002800680 | benign | Smith-Lemli-Opitz syndrome | 2022-03-25 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001510852 | SCV002093039 | likely benign | Smith-Lemli-Opitz syndrome | 2019-03-22 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004749707 | SCV005366614 | likely benign | DHCR7-related disorder | 2022-06-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |